Current and historical daily PE Ratio for Cryosite Ltd (
) from 2002 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Cryosite stock (ASX:CTE) PE ratio as of Apr 26 2024 is 26.56.
More Details
Cryosite Ltd (ASX:CTE) PE Ratio (TTM) Chart
Cryosite Ltd (ASX:CTE) PE Ratio (TTM) Historical Data
View and export this data going back to 2002. Start your Free Trial
Total 1242
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Cryosite PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-26 | 26.6 | 2024-02-22 | 19.7 |
| 2024-04-24 | 27.2 | 2024-02-21 | 19.7 |
| 2024-04-23 | 25.9 | 2024-02-20 | 19.7 |
| 2024-04-22 | 25.3 | 2024-02-19 | 19.7 |
| 2024-04-19 | 24.8 | 2024-02-16 | 21.3 |
| 2024-04-18 | 23.1 | 2024-02-15 | 21.3 |
| 2024-04-17 | 21.9 | 2024-02-14 | 21.3 |
| 2024-04-16 | 21.9 | 2024-02-13 | 21.3 |
| 2024-04-15 | 21.6 | 2024-02-12 | 20.3 |
| 2024-04-12 | 20.0 | 2024-02-09 | 20.3 |
| 2024-04-11 | 20.0 | 2024-02-08 | 20.3 |
| 2024-04-10 | 20.0 | 2024-02-07 | 20.3 |
| 2024-04-09 | 20.0 | 2024-02-06 | 22.7 |
| 2024-04-08 | 21.3 | 2024-02-05 | 20.3 |
| 2024-04-05 | 21.9 | 2024-02-02 | 20.5 |
| 2024-04-04 | 21.9 | 2024-02-01 | 20.5 |
| 2024-04-03 | 21.9 | 2024-01-31 | 22.7 |
| 2024-04-02 | 21.9 | 2024-01-30 | 22.7 |
| 2024-04-01 | 21.6 | 2024-01-29 | 22.7 |
| 2024-03-29 | 21.6 | 2024-01-26 | 23.3 |
| 2024-03-28 | 21.6 | 2024-01-25 | 23.3 |
| 2024-03-27 | 21.3 | 2024-01-24 | 23.3 |
| 2024-03-26 | 21.3 | 2024-01-23 | 23.3 |
| 2024-03-25 | 21.3 | 2024-01-22 | 23.3 |
| 2024-03-22 | 21.3 | 2024-01-19 | 23.3 |
| 2024-03-21 | 21.3 | 2024-01-18 | 23.3 |
| 2024-03-20 | 21.3 | 2024-01-17 | 23.3 |
| 2024-03-19 | 20.3 | 2024-01-16 | 21.9 |
| 2024-03-18 | 20.3 | 2024-01-15 | 20.8 |
| 2024-03-15 | 20.3 | 2024-01-12 | 20.8 |
| 2024-03-14 | 20.3 | 2024-01-11 | 20.3 |
| 2024-03-13 | 20.3 | 2024-01-10 | 19.4 |
| 2024-03-12 | 20.3 | 2024-01-09 | 19.4 |
| 2024-03-11 | 20.0 | 2024-01-08 | 19.4 |
| 2024-03-08 | 20.0 | 2024-01-05 | 19.1 |
| 2024-03-07 | 20.0 | 2024-01-04 | 18.9 |
| 2024-03-06 | 20.0 | 2024-01-03 | 18.9 |
| 2024-03-05 | 20.0 | 2024-01-02 | 18.9 |
| 2024-03-04 | 20.0 | 2024-01-01 | 18.9 |
| 2024-03-01 | 20.0 | 2023-12-29 | 18.9 |
| 2024-02-29 | 19.7 | 2023-12-28 | 19.1 |
| 2024-02-28 | 19.7 | 2023-12-27 | 20.7 |
| 2024-02-27 | 19.7 | 2023-12-22 | 21.0 |
| 2024-02-26 | 19.7 | 2023-12-21 | 21.7 |
| 2024-02-23 | 19.7 | 2023-12-20 | 21.7 |
Cryosite Ltd (ASX:CTE) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Cryosite Ltd
ISIN : AU000000CTE1
Description
Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers